Mitigating long-term and delayed adverse events associated with cancer treatment: implications for survivorship
Despite the importance of chemotherapy-associated adverse events in oncology practice
and the broad range of interventions available to mitigate them, limited systematic efforts …
and the broad range of interventions available to mitigate them, limited systematic efforts …
Emergence of extracellular vesicles as “liquid biopsy” for neurological disorders: boom or bust
Extracellular vesicles (EVs) have emerged as an attractive liquid biopsy approach in the
diagnosis and prognosis of multiple diseases and disorders. The feasibility of enriching …
diagnosis and prognosis of multiple diseases and disorders. The feasibility of enriching …
Effect of physical exercise on cognitive function after chemotherapy in patients with breast cancer: a randomized controlled trial (PAM study)
Background Up to 60% of breast cancer patients treated with chemotherapy is confronted
with cognitive problems, which can have a significant impact on daily activities and quality of …
with cognitive problems, which can have a significant impact on daily activities and quality of …
[HTML][HTML] 6th and 7th International consensus guidelines for the management of advanced breast cancer (ABC guidelines 6 and 7)
This manuscript describes the Advanced Breast Cancer (ABC) international consensus
guidelines updated at the last two ABC international consensus conferences (ABC 6 in …
guidelines updated at the last two ABC international consensus conferences (ABC 6 in …
Long-term fatigue and cognitive disorders in breast cancer survivors
Survivors of early-stage breast cancer may report treatment-related side effects that persist
for several years after the end of primary treatment. Among these, fatigue and cognitive …
for several years after the end of primary treatment. Among these, fatigue and cognitive …
Cognitive impairment after cancer treatment: mechanisms, clinical characterization, and management
B Fleming, P Edison, L Kenny - bmj, 2023 - bmj.com
Cognitive impairment is a debilitating side effect experienced by patients with cancer treated
with systemically administered anticancer therapies. With around 19.3 million new cases of …
with systemically administered anticancer therapies. With around 19.3 million new cases of …
Brain fog and fatigue following COVID-19 infection: an exploratory study of patient experiences of long COVID
Post-acute sequelae of SARS-CoV-2 (PASC) is a poorly understood condition with
significant impact on quality of life. We aimed to better understand the lived experiences of …
significant impact on quality of life. We aimed to better understand the lived experiences of …
Mechanisms of chemotherapy-induced neurotoxicity
Since the first clinical trials conducted after World War II, chemotherapeutic drugs have been
extensively used in the clinic as the main cancer treatment either alone or as an adjuvant …
extensively used in the clinic as the main cancer treatment either alone or as an adjuvant …
Supplementation with NAD+ and Its Precursors to Prevent Cognitive Decline across Disease Contexts
JM Campbell - Nutrients, 2022 - mdpi.com
The preservation of cognitive ability by increasing nicotinamide adenine dinucleotide
(NAD+) levels through supplementation with NAD+ precursors has been identified as a …
(NAD+) levels through supplementation with NAD+ precursors has been identified as a …
Chemotherapy-induced cognitive impairment and hippocampal neurogenesis: a review of physiological mechanisms and interventions
A wide range of cognitive deficits, including memory loss associated with hippocampal
dysfunction, have been widely reported in cancer survivors who received chemotherapy …
dysfunction, have been widely reported in cancer survivors who received chemotherapy …